2 unknown. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Unknown 2 |
| Phase 2 | 1 | Unknown 1 |
Follow Cardiomyopathy: new trials by email Literature Review of Cardiomyopathy trials Research Report on Cardiomyopathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cardiac Sympathetic Denervation for Prevention of Ventricular Tachyarrhythmias Cardiac Sympathetic Denervation (CSD), Routine Care - Sudden Cardiac Death, Ventricular Tachycardia | Phase 3 | Unknown | University of California, Los Angeles | 40 | 2021-07-26 | 2024-01-19 |
| Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation ATI-5923, Coumadin (warfarin) - Atrial Fibrillation, Atrial Flutter | Phase 2 / Phase 3 | Unknown | ARYx Therapeutics | 600 | 2008-05-01 | 2010-02-02 |
Cardiomyopathies (2) · Atrial Fibrillation (1) · Atrial Flutter (1) · Death, Sudden, Cardiac (1) · Myocardial Infarction (1) · Tachycardia, Ventricular (1) · Ventricular Fibrillation (1)
Arrhythmias, Cardiac (2) · Cardiovascular Diseases (2) · Heart Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Cardiac Conduction System Disease (1) · Death (1) · Death, Sudden (1) · Heart Arrest (1) · Infarction (1) · Ischemia (1) · Myocardial Ischemia (1) · Necrosis (1) · Tachycardia (1) · Vascular Diseases (1)
Warfarin (1) · tecarfarin (1)
ARYx Therapeutics (1) · University of California, Los Angeles (1)
United States (2)